BlackRock Ebitda from 2010 to 2024

BMEZ Stock  USD 15.66  0.10  0.64%   
BlackRock Health EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA will likely drop to about 879 M in 2024. During the period from 2010 to 2024, BlackRock Health EBITDA regression line of annual values had r-squared of  0.59 and arithmetic mean of  544,937,948. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
1.7 B
Current Value
879 M
Quarterly Volatility
653.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BlackRock Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BlackRock Health's main balance sheet or income statement drivers, such as Net Interest Income of 0.0, Interest Income of 0.0 or Depreciation And Amortization of 231.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 0.81 or Days Sales Outstanding of 0.0. BlackRock financial statements analysis is a perfect complement when working with BlackRock Health Valuation or Volatility modules.
  
Check out the analysis of BlackRock Health Correlation against competitors.

Latest BlackRock Health's Ebitda Growth Pattern

Below is the plot of the Ebitda of BlackRock Health Sciences over the last few years. It is BlackRock Health's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BlackRock Health's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

BlackRock Ebitda Regression Statistics

Arithmetic Mean544,937,948
Geometric Mean260,263,287
Coefficient Of Variation119.92
Mean Deviation575,611,533
Median113,229,299
Standard Deviation653,486,286
Sample Variance427044.3T
Range1.6B
R-Value0.77
Mean Square Error189216.4T
R-Squared0.59
Significance0.0008
Slope112,103,396
Total Sum of Squares5978620.6T

BlackRock Ebitda History

2024879 M
20231.7 B
20201.5 B

About BlackRock Health Financial Statements

BlackRock Health investors use historical fundamental indicators, such as BlackRock Health's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BlackRock Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA1.7 B879 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BlackRock Stock Analysis

When running BlackRock Health's price analysis, check to measure BlackRock Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Health is operating at the current time. Most of BlackRock Health's value examination focuses on studying past and present price action to predict the probability of BlackRock Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Health's price. Additionally, you may evaluate how the addition of BlackRock Health to your portfolios can decrease your overall portfolio volatility.